PMID: 42012820 Kanumilli N et al
A proper selection of diluent will provide accurate dosage and help avoid contamination and peptide quality
I think thats just part of the inherent bias towards the treatment of people with obesity, feeling like its cheating or not necessary. The list price for Wegovy is around $1,300 per month, and for Ozempic, around $1,000
Statistical Analyses Analyses were performed using SAS version 9.4 or higher (SAS Institute, Inc., Cary, NC, US)
Releasing Q2 earnings on Monday, Hims & Hers Co-Founder and CEO Andrew Dudem said users of its personalized GLP-1 treatment plans had lost an average 10.3% of their body weight over six months, and that only 25% of them had discontinued treatment, particularly encouraging when considering discontinuation rates in certain publicly available studies reached approximately 80% percent by six months. Saying that personalized treatments allow patients to receive clear treatment instructions and educational content while also accessing tools such as water intake trackers and calorie counters, Dudem complained of pushback from traditional incumbents. During its own earnings call on Wednesday, Novo Nordisk doubled down against GLP-1 compounders that it says are still around despite the end of an FDA-granted grace period in May